Table 2.

ELISA and IHC quantification of IGF-1R in patient tumor samples.

Sample	αIR3 binding (% of NWTb3 ± SD)	IGF-1R IHC (% positive cells)
129	16.5 ± 0	100
130	16.5 ± 3.0	99
131	7.3 ± 0.2	100
132	14.6 ± 0.4	95
133	15.8 ± 1.9	100
134	14.2 ± 1.3	20
135	12.3 ± 1.3	10
136	4.8 ± 3.7	5
137	20.0 ± 0.2	40
138	18.6 ± 0.6	40